Blood pressure effects of CPAP in nonresistant and resistant hypertension associated with OSA: A systematic review of randomized clinical trials
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Obstructive sleep apnea (OSA) is a rather common chronic disorder, associated with increased prevalence of hypertension. The pathophysiological mechanisms for hypertension in OSA are at least in part linked to intermittent hypoxia developed during nightly hypopneas and apneas. Hypoxemia stimulates sympathetic overactivity, systemic inflammation, oxidative stress, and endothelial dysfunction. However, it appears that intermittent hypoxemia is not the only factor in the development of hypertension in OSA. Supplemental oxygen therapy that improved oxyhemoglobin saturation to similar levels to those achieved with CPAP treatment did not reduce BP. In this scenario, it could be proposed that hypoxemia acts as a trigger of sympathetic overdrive, which when set is the main factor in the development of hypertension in OSA. This review appraises evidence provided by randomized controlled trials on the BP-lowering effectiveness of continuous positive airway pressure (CPAP) treatment of OSA patients with nonresistant and resistant hypertension. It suggests that CPAP treatment is more effective in treating resistant hypertension than nonresistant hypertension. A possible explanation is that sympathetic overactivity and altered vascular reactivity in OSA could be more severe in resistant hypertension than in nonresistant hypertension. An intricate interaction among compliance, adherence, and their interaction with demographic characteristics, genetic factors, and comorbidities of the population included might explain the differences found between trials on their influence over the antihypertensive effectiveness of CPAP. Further long-term trials are needed in hypertensive OSA patients to assess whether CPAP treatment in OSA patients consistently restores physiological nocturnal BP fall and adjusts resting and circadian heart rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Increased Prevalence of Sleep-Disordered Breathing in Adults
Peppard, P. E., Young, T., Barnet, J. H., Palta, M., Hagen, E. W., & Hla, K. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws342 · Cited by 4,618
Nieto, F. J. (2000) · JAMA · doi:10.1001/jama.283.14.1829 · Cited by 3,369
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
DURÁN, J., ESNAOLA, S., RUBIO, R., & IZTUETA, Á. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2005065 · Cited by 1,407
Obstructive sleep apnoea syndrome – an oxidative stress disorder
Lavie, L. (2003) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0261 · Cited by 993 · cited 1×
“The mechanisms for hypertension in OSA are incompletely understood, but are likely to be related to intermittent hypoxia (45–47), which stimulates sympathetic overactivity, systemic inflammation (46), oxidative stress (47), and endothelial dysfunction (48).”
BackgroundRyan, S., Taylor, C. T., & McNicholas, W. T. (2005) · Circulation · doi:10.1161/circulationaha.105.556746 · Cited by 970
Pathophysiology of Adult Obstructive Sleep Apnea
Eckert, D. J., & Malhotra, A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200707-114mg · Cited by 719
Martínez-García, M.-A., Capote, F., Campos-Rodríguez, F., Lloberes, P., Díaz de Atauri, M. J., Somoza, M., Masa, J. F., González, M., Sacristán, L., Barbé, F., et al. (2013) · JAMA · doi:10.1001/jama.2013.281250 · Cited by 685
Prospective Study of Sleep-disordered Breathing and Hypertension: The Sleep Heart Health Study
O'Connor, G. T., Caffo, B., Newman, A. B., Quan, S. F., Rapoport, D. M., Redline, S., Resnick, H. E., Samet, J., & Shahar, E. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1809oc · Cited by 390
CPAP versus Oxygen in Obstructive Sleep Apnea
Gottlieb, D. J., Punjabi, N. M., Mehra, R., Patel, S. R., Quan, S. F., Babineau, D. C., Tracy, R. P., Rueschman, M., Blumenthal, R. S., Lewis, E. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306766 · Cited by 366 · cited 1×
“(49) reported that even though supplemental oxygen therapy improved oxyhemoglobin saturation to similar levels to those achieved with CPAP treatment, only the latter reduced BP significantly.”
BackgroundHaas, D. C., Foster, G. L., Nieto, F. J., Redline, S., Resnick, H. E., Robbins, J. A., Young, T., & Pickering, T. G. (2005) · Circulation · doi:10.1161/01.cir.0000154540.62381.cf · Cited by 343
Robinson, G. V., Smith, D. M., Langford, B. A., Davies, R. J. O., & Stradling, J. R. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00062805 · Cited by 314
Gaddam, K., Pimenta, E., Thomas, S. J., Cofield, S. S., Oparil, S., Harding, S. M., & Calhoun, D. A. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2009.96 · Cited by 289 · cited 1×
“In one study, use of an aldosterone antagonist in OSA patients with resistant hypertension lowered their BP (62).”
BackgroundImprovement of Mild Sleep-disordered Breathing with CPAP Compared with Conservative Therapy
REDLINE, S., ADAMS, N., STRAUSS, M. E., ROEBUCK, T., WINTERS, M., & ROSENBERG, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9709042 · Cited by 240
Iftikhar, I. H., Valentine, C. W., Bittencourt, L. R. A., Cohen, D. L., Fedson, A. C., Gíslason, T., Penzel, T., Phillips, C. L., Yu-sheng, L., Pack, A. I., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000372 · Cited by 215
Gonzaga, C. C., Gaddam, K. K., Ahmed, M. I., Pimenta, E., Thomas, S. J., Harding, S. M., Oparil, S., Cofield, S. S., & Calhoun, D. A. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27878 · Cited by 188 · cited 1×
“Other mechanisms, such as increased renin-angiotensin system activity (59,60) and rising of plasma aldosterone levels (60,61), may also participate in the development of resistant hypertension in OSA.”
BackgroundLiu, L., Cao, Q., Guo, Z., & Dai, Q. (2016) · The Journal of Clinical Hypertension · doi:10.1111/jch.12639 · Cited by 160
Non-dipping pattern of hypertension and obstructive sleep apnea syndrome
Wolf, J., Hering, D., & Narkiewicz, K. (2010) · Hypertension Research · doi:10.1038/hr.2010.153 · Cited by 156
Muxfeldt, E. S., Margallo, V., Costa, L. M. S., Guimarães, G., Cavalcante, A. H., Azevedo, J. C. M., de Souza, F., Cardoso, C. R. L., & Salles, G. F. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04852 · Cited by 142
Walia, H. K., Li, H., Rueschman, M., Bhatt, D. L., Patel, S. R., Quan, S. F., Gottlieb, D. J., Punjabi, N. M., Redline, S., & Mehra, R. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3946 · Cited by 104 · cited 1×
“The Heart Biomarker Evaluation in Apnea Treatment (HeartBEAT) study, a randomized clinical trial (RCT) carried out at Brigham and Women’s Hospital, Case Medical Center, Johns Hopkins Medical Center, and Veterans Affairs Boston Healthcare System, reported that untreated severe OSA was associated with a greater prevalen…”
Method
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Diagnosis and Management of Obstructive Sleep Apnea: A Review
Gottlieb, D. J., & Punjabi, N. M. (2020) · JAMA · doi:10.1001/jama.2020.3514 · Cited by 1,482
Metrics of sleep apnea severity: beyond the apnea-hypopnea index
Malhotra, A., Ayappa, I., Ayas, N., Collop, N., Kirsch, D., Mcardle, N., Mehra, R., Pack, A. I., Punjabi, N., White, D. P., et al. (2021) · SLEEP · doi:10.1093/sleep/zsab030 · Cited by 489
“Conversely, the severity of blood pressure elevation at baseline is strongly associated with blood pressure reduction following PAP therapy, with particularly large effects noted in patients with resistant hypertension, again emphasizing the importance of the individual response to OSA as a marker of disease [103, 109…”
BackgroundApneic Sleep, Insufficient Sleep, and Hypertension
Mansukhani, M. P., Covassin, N., & Somers, V. K. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11780 · Cited by 52
Upper Airway Stimulation vs Positive Airway Pressure Impact on BP and Sleepiness Symptoms in OSA
Walia, H. K., Thompson, N. R., Strohl, K. P., Faulx, M. D., Waters, T., Kominsky, A., Foldvary-Schaefer, N., & Mehra, R. (2020) · Chest · doi:10.1016/j.chest.2019.06.020 · Cited by 34
Metadata
- Authors
- Feldstein, C. A.
- Venue
- Clinical and Experimental Hypertension
- Publisher
- Informa UK Limited
- Published
- 2016-05-09
- Volume
- 38
- Issue
- 4
- Pages
- 337-346
- ISSN
- 0148-3927 (ISSN-L)
- 1064-1963
- 1525-6006
- OpenAlex
- W2346080265
- Cited by
- 51
- References
- 21
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.